LF Woodford Equity Income Fund C Sterling Accumulation

Investment Style Details30/04/2019
Morningstar Style Box®
Equity Style
SizeRel to Cat
Average Mkt Cap (Mil)GBP 1055-
Market Capitalisation% of Equity
Giant0.00
Large3.16
Medium25.35
Small43.32
Micro28.17
Valuations and Growth RatesEquity PortfolioRelative to Category
Price/Prospective Earnings9.530.80
Price/Book1.501.08
Price/Sales0.961.01
Price/Cash Flow9.391.32
Dividend-Yield Factor4.540.90
 
Long-Term Projected Earnings Growth12.991.62
Historical Earnings Growth505.606.32
Sales Growth3.715.41
Cash-Flow Growth-5.53-1.24
Book-Value Growth-17.37-5.27
 
Asset Allocation30/04/2019
Asset Allocation
 % Long% Short% Net Assets
Stock90.140.0090.14
Bond0.020.000.02
Property0.200.000.20
Cash0.682.84-2.16
Other11.800.0011.80
World Regions30/04/2019
 % of EquityRelative to Category
United States11.292.79
Canada0.000.00
Latin America0.000.00
United Kingdom85.760.94
Eurozone1.600.66
Europe - ex Euro1.351.10
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.00
Japan0.000.00
Australasia0.000.00
Asia - Developed0.000.00
Asia - Emerging0.000.00
 
Sector Weightings30/04/2019
 % of EquityRelative to Category
Basic MaterialsBasic Materials1.180.18
Consumer CyclicalConsumer Cyclical26.511.62
Financial ServicesFinancial Services22.360.95
Real EstateReal Estate9.212.44
Consumer DefensiveConsumer Defensive3.150.27
HealthcareHealthcare23.612.82
IndustrialsIndustrials11.281.00
TechnologyTechnology2.700.91
 
Top 10 Holdings30/04/2019
 Portfolio
Total Number of Equity Holdings74
Total Number of Bond Holdings0
Assets in Top 10 Holdings45.07
NameSectorCountry% of Assets
Barratt Developments PLC102United Kingdom7.51
Burford Capital Ltd103United Kingdom5.97
Taylor Wimpey PLC102United Kingdom5.33
Provident Financial PLC103United Kingdom4.80
Theravance Biopharma Inc206United States4.77
Benevolent Ai Link Weif A-4.48
IP Group PLC103United Kingdom3.30
Autolus Therapeutics PLC ADR206United Kingdom3.18
Countryside Properties PLC104United Kingdom3.16
Oxford Nanopore Tech Ord-2.58
 
 
Advertisement
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites